Toronto, Ontario–(Newsfile Corp. – May 27, 2021) – Microdose Psychedelic Insights (“Microdose”), your guide to the business of psychedelics, in partnership with The Conscious Fund, the most active VC fund in the psychedelic space, is pleased to present the next edition of Psychedelic Capital.
The next edition of the psychedelic investment series will be on Monday, May 31, 2021, at 1:30 PM EST. The PsyCap May edition will feature engaging presentations from Psyched Wellness (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) Circadian Wellness Corp., Nextage Therapeutics (TLV: NXTG)as well as panel discussions on the topic of Financial Media and Equality in the Boardroom.
Details and schedule of the May PsyCap are as follows:
1:30 PM: Intro
Featuring Henri Sant-Cassia & Richard Skaife.
1:45 PM: Psyched Wellness (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9)
Featuring Jeffrey Stevens, Terry Booth, Rebecca Brown
Psyched Wellness is a Canadian health supplements company dedicated to protect, restore and regain a healthier body and mind through the production and distribution of artisanal, medicinal mushrooms.
2:20 PM: Financial Media
Featuring Bryan McGovern, Frank Lane, Ariadna Peretz, James Hallifax
2:55 PM: Circadian Wellness Corp.
Featuring Alex Wolfe
Circadian Wellness focuses on mushroom farming, extraction, and one-of-a-kind delivery methods with the highest bioavailability. Since inception, research breakthroughs have made our licensed proprietary Quicksome™ delivery system scalable commercially by delivering the highest purity and quality mushroom extracts and isolates. By extracting from the flowering body rather than mycelium, we are able to deliver the highest quality at maximum potency.
3:30 PM: Equality in Boardroom
Featuring Susan Chapelle
4:05 PM: Nextage Therapeutics (TLV: NXTG)
Featuring Abraham Dreazen
Bringing together the ingenuity of researchers and startups with the know-how of pharmaceutical organizations to create groundbreaking quality responsible products and solutions. Born out of Nextar, Israel’s leading CDMO for the development and manufacturing of pharmaceuticals and medical devices.
4:05 PM: Special Guests
May 31, 2021 at 1:30pm Eastern
Presentations are 30 minutes in length, with 10 minutes always allocated to a one-on-one Q&A session with the audience. Psychedelic Capital features the top companies, latest IPOs, newest opportunities and deepest insights into the emerging psychedelic space. Live networking with all the attendees is available prior and during the event.
– ENDS –
Notes to Editors
To request media accreditation, or to arrange interviews with key personnel please contact:
About Microdose Psychedelic Insights
Microdose Psychedelic Insights aims to unlock the potential of psychedelics through Industry events, market intelligence, original, evidence-based content, strategy and community. We enable and empower society at large to make better, more mindful decisions about psychedelics and its intersection with healthcare, medicine and personal growth. We work with the industry’s most influential stakeholders, some of the world’s best-known brands and an unrivalled network of scientists, researchers, analysts, innovators, investors and advisors.
This online event programming is dedicated to providing investment grade information for the nascent psychedelic sector and presents a curated group of CEOs, financial experts, thought leaders and investment luminaries from around the globe. Presentations are 30 minutes in length, with 10 minutes always allocated to a one-on-one Q&A session with the audience. Psychedelic Capital features the top companies, latest IPOs, newest opportunities and deepest insights into the emerging psychedelic space.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/85356